antivirals Flashcards
(39 cards)
antivirals
-Viruses use host cell’s metabolic pathways for reproduction -> limits MOA for antiviral drug action
-Antibacterials & Antifungals have little or no effect on viruses
-Most antivirals are antimetabolites of endogenous nucleosides and prevent replication of viral nucleic acid
-Some antivirals inhibit the uncoating of viral nucleic acid or inhibit post translation of viral proteins
enterovirus- D68
-one of more than 100 non-polio enteroviruses
-Symptoms:
-Mild - fever, runny nose, sneezing, cough, and body and muscle aches
-Severe - wheezing and difficulty breathing
-Spreads via respiratory secretions
-Prevention – wash hands, cover sneeze & cough
-Surge – Summer & Fall
-tx - supportive
ebola
-Previously known as Ebola hemorrhagic fever
-can cause disease in humans and nonhuman primates
-spread through direct contact
-broken skin or mucous membranes in, for example, the eyes, nose, or mouth
-Wash with soap & water or use alcohol based cleanser
-Treatment
-No FDA-approved vaccine or medicine (e.g., antiviral drug) is available for Ebola
-Early supportive care
COVID-19
-SARS-Cov-2:
-Coronavirus
-Serious Acute Respiratory Syndrome
-Viral respiratory disease
COVID-19 vaccines
-mRNA:
-Comirnaty® - Pfizer/BioNTech
-Spikevax® - Moderna
-Adjuvanted: Novavax
COVID-19 tx
-Inpatient
-Remdesivir (Veklury) – Antiviral IV tx
-Tocilizumab (Actemra) - IL-6 inhibitor IV tx
-Dexamethasone – IV/PO IN COMBO ^
-Outpatient
-Molnupiravir (Lagevrio®) – Antiviral PO - EUA
-Nirmatrelvir and Ritonavir (Paxlovid®) - Antiviral PO - EUA
-< 5 days of being sick
-many DDIs
not recommended or authorized tx for COVID
Ivermectin
Doxycycline
Hydroxychloroquine
Azithromyzin
Colchicine
COVID-19 prevention
-pre-exposure prophylaxis
-pemivibart- antiviral- EUA -> single IV infusion
herpes virus infections
-Herpes viruses are DNA viruses
-Herpes Simplex Virus (HSV):
-Herpes genitalis (HSV II)
-Herpes labialis (cold sores) (HSV I)
-Herpetic keratoconjunctivitis
-Herpes encephalitis
-Varicella-zoster virus (VZV)
-Chicken pox (varicella)
-Shingles (herpes zoster)
-Cytomegalovirus (CMV)*
-CMV retinitis
-CMV esophagitis
-CMV colitis
-* most CMV diseases occur in immunocompromised pts*
drugs for herpes virus
-All are nucleoside analogs, except foscarnet & docosanol
-Most contain purine/pyrimidine base
-Prodrugs that are converted to active drug usually in infected host cell -> selective toxicity & prevention of synthesis of viral RNA
-Viral resistance develops with all, varies with drug and viral pathogen
-acyclovir
-valacyclovir
-famciclovir
-penciclovir
-docosanol
shingriz SC injection
-vidarabine
-trifluridine
-ganciclovir
-valganciclovir
-cidofovir
-foscarnet
-ganciclovir
-fomiversin
HSV and VZV: acyclovir
-PO, IV, topical
-inhibit viral replication, does not cure-only reduces the pain, severity & symptoms of the outbreak, shortens its duration and may prevent the overall number of recurrences.
-ADRs - itching, hives, nephrotoxic - elevated BUN & creatinine, N,V,D, headache, paresthesias
-PO form – low bioavailability (5 times/day)- limiting
-IV for serious or systemic infections
-Topical – used for genitalis
-Available as oral suspension for chickenpox in kids
HSV and VZV: valacyclovir
-PO
-valtrex
-ADRs- less than acyclovir, N/V, headaches
-increase bioavailability- less frequent dosing
-valacyclovir and famciclovir are more effective than acyclovir for shingles
HSV and VZV: famciclovir
-PO
-ADRs: headache, fatigue, diarrhea
-increase bioavailability – less frequent dosing
-valacyclovir and famciclovir are more effective than acyclovir for shingles
HSV and VZV: penciclovir
-topical
-Active metabolite of famciclovir
-Topical for herpes labialis
-Potentially used for Epstein-Barr virus
-ADRs – mild erythema, headache
HSV and VZV: docosanol
-First OTC topical for herpes labialis
-Limited info available
-ADRs – local irritation, headache
-NOT a nucleoside analog
varicella-zoster vaccine: shingrix SC injection
-Indications: Prevention of herpes zoster (shingles) in pts > 50 years old and in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression (not on test)
-Zoster Vaccine Recombinant, Adjuvanted
-More potent than chickenpox vaccine
-Can reduce shingles cases by 50% and patients who get shingles will get milder cases. Also, in pts who get shingles - 1/3 less likely to develop postherpetic neuralgia
TX of HSV (ocular infection)
-vidarabine -(ophth oint) – blocks vision, use HS (at bed)
-trifluridine -(ophth sol.)
-both used for keratoconjunctivitis and recurrent epithelial keratitis due to HSV I and II.
-ADRs: burning, irritation, lacrimation
CMV: ganciclovir
-PO, IV, implant
-Used for TREATMENT of CMV retinitis in immunocompromised pts and PREVENTION of CMV diseases in HIV and transplant pts.
-PO form has low bioavailability (use for long term suppression of CMV)
-ADRs: !bone marrow suppression! (BMS)- dose limiting, H/A, confusion, !retinal detachment!, liver and renal dysfunction, rash, fever, gi effects
-Mutagenic, long term carcinogenic effects
CMV: valganciclovir
-PO
-Same indication as ganciclovir, prodrug – can give less frequently
CMV: cidofovir
-IV
-Same indications as ganciclovir
-Reserved use for resistant viruses
-Higher incidence of more serious adverse effects (nephrotoxicity, neutropenia, metabolic acidosis)
CMV: foscarnet
-IV
-NOT nucleoside
-Tx of CMV retinitis in immunocompromised pts when ganciclovir alone has failed!!
-Often given in combo with ganciclovir to reduce toxicity
-IV hydration before to prevent renal toxicity
-Also used for acyclovir resistant HSV infx and shingles
-ADRs: fever, H/A, renal impairment, !acute renal failure, N,V,D, !hematologic deficiencies, !seizures, !cardiac arrhythmias, !heart failure and !pancreatitis
ocular antivirals for CMV
-Ganciclovir implant – CMV retinitis
-Fomiversin inj – CMV retinitis
influenza (dont need to know)
-U.S. Epidemiology:
-Annual Infections: 25-50 million
-Annual Hospitalizations: 226,000
-Annual Mortality: 19,000 -36,000
-Types A & B
-Type A - moderate/severe illness- from 0 to 100
-Type B - milder - primarily affects children
-Clinical presentation: Abrupt onset of fever, malaise, sore throat and non-productive cough. Disease peaks b/w December & March
-Complications: Pneumonia, myocarditis, Reyes syndrome
flu vaccine guidlines
-Vaccination now recommended for ALL persons > 6 months old
-All children 6 months – 8 years old being vaccinated for first time should receive 2 doses (4 weeks apart) - DONT NEED TO KNOW THIS PART